Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Rococo Co, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 12% Increase in Ordinary Profit for The Current Fiscal Year
5868 Rococo Co.Ltd. 【J-GAAP】
Earnings ReportRococo Co.Ltd. <5868> [TSE Std] announced its financial results after the market closed on February 14th (17:00). The consolidated ordinary profit for the fiscal year ending December 2024 decreased 2.0% from the previous period to 441 million yen, although it exceeded the initial forecast of 360 million yen. In the fiscal year ending December 2025, the profit is expected to expand to 11.6% to 492 million yen. This will be the fifth consecutive term of revenue growth.
At the same time, the company increased the annual dividend for the previous term from 20 yen to 30 yen (compared to 20 yen in the prior term). For the current term, the company plans to remove the commemorative dividend of the previous term and set the dividend for this term at an ordinary dividend of 25 yen.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit surged 2.6 times that of the same period last year, reaching 190 million yen. The operating profit margin significantly improved from 4.6% in the same period last year to 9.1%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 7,175 | 480 | 450 | 289 | 110.0 | 20 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 7,803 | 426 | 441 | 278 | 75.1 | 30 | Feb 14, 2025 | J-GAAP |
YoY | +8.8% | -11.3% | -2.0% | -3.8% | -31.7% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 7,711 | 350 | 360 | 231 | 62.1 | 20 | Aug 14, 2024 | J-GAAP |
Dec, 2024 Results | 7,803 | 426 | 441 | 278 | 75.1 | 30 | Feb 14, 2025 | J-GAAP |
Revision Rate | +1.2% | +21.7% | +22.5% | +20.3% | +20.9% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 3,766 | 46 | 43 | 11 | 3.2 | 0 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 7,175 | 480 | 450 | 289 | 110.0 | 20 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 7,803 | 426 | 441 | 278 | 75.1 | 30 | Feb 14, 2025 | J-GAAP |
Dec, 2025 Guidance | 8,610 | 496 | 492 | 331 | 88.9 | 25 | Feb 14, 2025 | J-GAAP |
YoY | +10.3% | +16.4% | +11.6% | +19.1% | +18.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 1,850 | 86 | 74 | 39 | 14.8 | 4.6 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 1,941 | 122 | 126 | 80 | 21.9 | 6.3 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 1,825 | -76 | -83 | -69 | -19.9 | -4.2 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,944 | 189 | 208 | 145 | 39.4 | 9.7 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 2,093 | 191 | 190 | 122 | 32.9 | 9.1 | Feb 14, 2025 | J-GAAP |
YoY | +13.1% | +122.1% | +156.8% | +212.8% | +122.0% |
Related Articles
ProjectHoldings, Break Evenin Ordinary Profit for The Current Fiscal Year
NAKAYO, Postponed Dividend for This Fiscal Year
f-code, 42% Increase in Net Income, Update Record High for Third Consecutive Term
Noile-Immune Biotech, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
AEON Fantasy, The Current Fiscal Year Net Income Revised Downward to a Loss, Dividend Revised down by 5 yen
Scala, First Half Net Income Turns to Profit, Exceeds Full-Year Plan
kaihan, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
baby calendar, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 60% Increase in Ordinary Profit for The Current Fiscal Year
Daikokuya Holdings, The Current Fiscal Year Net Income Loss Widened in Downward Revision
Kanamic Network, Oct-Dec (1Q) Ordinary Profit Increases by 19%